深度NCA:一种深度学习方法,用于对药物动力学数据进行非分区分析
Gengbo Liu1, Logan Brooks1, John Canty2
1Modeling and Simulation/Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
CPT: pharmacometrics & systems pharmacology
|March 11, 2024
概括
深度NCA是一种深度学习模型,可以从稀疏样本中改善药理动力学 (PK) 参数预测. 这种新的方法通过提供更少的数据点提供准确的非分区分析 (NCA) 来提高药物开发效率.
科学领域:
- 药理动力学 药理动力学
- 制药指标 (Pharmacometrics) 是一个指标.
- 计算生物学 计算生物学
背景情况:
- 非分组分析 (NCA) 是一种标准模型独立的药理动力学 (PK) 评估方法.
- 传统的NCA方法在稀疏的PK采样中表现出较低的准确性.
- 稀缺的PK数据是药物开发中的一个常见挑战,可能导致效率低下的研究设计.
研究的目的:
- 引入Deep-NCA,这是一种深度学习 (DL) 模型,旨在提高关键非分区PK参数的预测准确性.
- 在有限的 PK 样本数据的情况下解决传统 NCA 的局限性.
- 在药物开发早期提供更有效的PK分析方法.
主要方法:
- 开发一个深度学习模型,Deep-NCA,用于PK参数估计.
- 使用合成PK数据训练DL模型.
- 实施患者特定的规范化技术,用于数据预处理.
- 对六种新药在不同剂量方案下的模拟数据的深度NCA性能验证.
主要成果:
- 深度NCA在多种模拟药物和剂量条件中表现出有效的泛化.
- 在分析稀疏的PK数据时,DL模型显著优于传统的NCA方法.
- 即使样本可用性有限,也可以准确预测关键非分区PK参数.
结论:
- 深度NCA在将DL应用于PK研究方面取得了重大进展,特别是在稀疏数据场景中.
- 开发的方法为稀疏的PK样本提供了传统NCA的强大而准确的替代方案.
- 进一步验证可以将深度NCA定位为通过减少所需的PK样本数量来提高药物开发效率的有价值工具.
相关概念视频
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62
Model Approaches for Pharmacokinetic Data: Compartment Models
97
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
97
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
91
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
91
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
127
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
127
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Mechanistic Models: Overview of Compartment Models
83
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
83


